News

F.D. Flam: There’s a ‘double-edged sword’ in your stomach Trillions of microbes live in the digestive tract alone, a menagerie estimated to contain more than 1,000 species.
Discover how atrophic gastritis silently damages stomach tissue while increasing cancer risk, often going undiagnosed for years.
For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) yields better event-free survival ...
During the procedure, a section of the upper part of the stomach wall is attached to the LOS. Then, at the top of the stomach (fundus) and parallel to the oesophagus, the device is sewn into a pocket ...
Key Takeaways The MATTERHORN trial showed improved EFS and OS with durvalumab plus chemotherapy in gastric/GEJ cancer patients compared to chemotherapy alone. Durvalumab treatment resulted in a ...
Once gastric cancer is diagnosed, the results of any physical exams, biopsies, imaging, and procedures are used to determine the clinical stage, which helps to plan future treatment.
Gastric cancer diagnosed at advanced stages is associated with poor survival, but detection during early stages allows for several therapeutic interventions to improve outcomes, according to study ...
Yelena Y. Janjigian, MD, discusses how to manage the potential adverse events of pembrolizumab when using the recently approved combination of pembrolizumab plus trastuzumab and chemotherapy.
Understand Meckel's Diverticulum: its causes, symptoms, risks, diagnosis, and treatment options for this common congenital anomaly.
Weight loss Experimental drug looks to be gastric bypass surgery in pill form Daily drug creates temporary coating in small intestine.
Gastric cancer patient insights: Patient-reported outcomes and real-world perspectives from the gastric cancer patient community.. If you have the appropriate software installed, you can download ...
Intraperitoneal and intravenous paclitaxel plus S-1 versus intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis: Results from the multicenter, randomized, phase 3 ...